Association of Serum Levels of Fibroblast Growth Factor Receptor-3 and Cytokeratin-19 with Invasive and Non-invasive Bladder Cancer in a Sample of the Iraqi Population
Iraqi Journal of Medical Sciences · 29.06.2026 · 24 (1) · 162-168
DOI: 10.22578/wystmg37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 29.06.2026. Verfasst von Hasan N. Smeasm und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Bladder cancer (BC) is the tenth most prevalent cancer worldwide. The fibroblast growth factor receptor 3 (FGFR3) controls essential signaling pathways that govern several cellular processes, including proliferation and migration. Cytokeratin-19 (CYFRA21-1) is a protein belonging to the intermediate filament family that serves as an essential component of the cellular cytoskeleton. Although FGFR3 and CYFRA21-1 have been reported as prognostic factor in several malignancies, their association with muscle-invasive bladder cancers (MIBC) and non-muscle-invasive bladder cancers (NMIBC) has not yet been well-studied.
Objective
To determine the association of FGFR3 and CYFRA21-1 levels with MIBC and NMIBC in a sample of the Iraqi population.
Methods
This case-control study involved 40 NMIBC and 40 MIBC participants. The serum levels of FGFR3 and CYFRA21-1 were determined using the enzyme-linked immunosorbent assay (ELISA) technique.
Results
In the MIBC patients\' group, smoking was significantly more prevalent than in the NMIBC group. FGFR3 levels were significantly higher in NMIBC groups. While CYFRA21-1 significantly increased in MIBC groups. According to the logistic regression model, CYFRA21-1 levels are associated with an increased risk of developing MIBC disease by nearly 2-fold (odd ratio: 1.44, 95% confidence interval: 1.31-1.57, p value <0.001).
Conclusion
CYFRA21-1 levels were associated with the development of MIBC and could be used as a predictive marker for the development of the disease in a sample of the Iraqi population.Keywords Muscle invasive bladder cancer; non-muscle invasive bladder cancer; fibroblast growth factor 3 receptor; CYFRA21-1.
Zitieren
APA
Smeasm, H. N., Al-Timimi, R. J. M., & Mohammed, S. H. (2026). Association of Serum Levels of Fibroblast Growth Factor Receptor-3 and Cytokeratin-19 with Invasive and Non-invasive Bladder Cancer in a Sample of the Iraqi Population. Iraqi Journal of Medical Sciences, 24(1), 162-168. https://doi.org/10.22578/wystmg37
Vancouver
Smeasm HN, Al-Timimi RJM, Mohammed SH. Association of Serum Levels of Fibroblast Growth Factor Receptor-3 and Cytokeratin-19 with Invasive and Non-invasive Bladder Cancer in a Sample of the Iraqi Population. Iraqi Journal of Medical Sciences. 2026;24(1):162-168. doi:10.22578/wystmg37
BibTeX
@article{Smeasm2026,
author = {Smeasm, Hasan N. and Al-Timimi, Raid J. M. and Mohammed, Saif H.},
title = {Association of Serum Levels of Fibroblast Growth Factor Receptor-3 and Cytokeratin-19 with Invasive and Non-invasive Bladder Cancer in a Sample of the Iraqi Population},
journal = {Iraqi Journal of Medical Sciences},
year = {2026},
volume = {24},
number = {1},
pages = {162--168},
doi = {10.22578/wystmg37}
}
EUVIMED